Social media … Is it a dream or nightmare?
Marketers dream of social media’s reach. Patients are using it — learning about their conditions — and talking to their doctors about what they’ve discovered.
But, it can become a regulatory nightmare for drug- and devicemakers if well-designed policies and procedures aren’t in place.
Many drug and device companies have a successful social media presence. How can you join them, reaping the sales and marketing benefits while satisfying the FDA at the same time?
You can make the dream come true — and learn much more — when you register to attend the FDAnews Social Media Regulatory Affairs Summit on June 24-25, 2015, at the National Press Club in Washington, DC.
